Description: GSK620 (GSK-620) is a novel, potent and orally bioactive pan-BD2 (Bromodomain) inhibitor with anti-inflammatory activity.

References: The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. J Med Chem. 2020;63(17):9093-9126.

纯度：≥98%

CAS：2088410-46-0